NHANES 2011-2014 Reveals Decreased Cognitive Performance in U.S. Older Adults with Metabolic Syndrome Combinations
- PMID: 37047872
- PMCID: PMC10093810
- DOI: 10.3390/ijerph20075257
NHANES 2011-2014 Reveals Decreased Cognitive Performance in U.S. Older Adults with Metabolic Syndrome Combinations
Abstract
A relationship between metabolic syndrome and cognitive impairment has been evidenced across research; however, conflicting results have been observed. A cross-sectional study was conducted on 3179 adults older than 60 from the 2011-2014 National Health and Nutrition Examination Survey (NHANES) to analyze the relationship between metabolic syndrome and cognitive impairment. In our results, we found that adults with abdominal obesity, high triglycerides, and low HDL cholesterol had 4.39 fewer points in the CERAD immediate recall test than adults without any metabolic syndrome factors [Beta = -4.39, SE = 1.32, 17.75 (1.36) vs. 22.14 (0.76)]. In addition, people with this metabolic syndrome combination exhibited 2.39 fewer points in the CERAD delayed recall test than those without metabolic syndrome criteria [Beta = -2.39, SE = 0.46, 4.32 (0.49) vs. 6.71 (0.30)]. It was also found that persons with high blood pressure, hyperglycemia, and low HDL-cholesterol levels reached 4.11 points less in the animal fluency test than people with no factors [Beta = -4.11, SE = 1.55, 12.67 (2.12) vs. 16.79 (1.35)]. These findings suggest that specific metabolic syndrome combinations are essential predictors of cognitive impairment. In this study, metabolic syndrome combinations that included obesity, fasting hyperglycemia, high triglycerides, and low HDL-cholesterol were among the most frequent criteria observed.
Keywords: NHANES; cognitive impairment; high triglycerides; hyperglycemia; low HDL–cholesterol; metabolic syndrome; obesity; older adults.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Nut and seed consumption is inversely associated with metabolic syndrome in females but not males: findings from the 2005-2018 NHANES data.Eur J Nutr. 2023 Sep;62(6):2415-2427. doi: 10.1007/s00394-023-03157-1. Epub 2023 Apr 28. Eur J Nutr. 2023. PMID: 37115204 Free PMC article.
-
Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults.Nutr J. 2024 Jul 17;23(1):79. doi: 10.1186/s12937-024-00983-9. Nutr J. 2024. PMID: 39020341 Free PMC article.
-
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011-2014).J Alzheimers Dis. 2022;86(1):125-134. doi: 10.3233/JAD-215250. J Alzheimers Dis. 2022. PMID: 35001890
-
Gender differences in the impact of metabolic syndrome components on mortality in older people: A systematic review and meta-analysis.Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1452-1464. doi: 10.1016/j.numecd.2020.04.034. Epub 2020 May 12. Nutr Metab Cardiovasc Dis. 2020. PMID: 32600955
-
Obesity, Metabolic Syndrome, and Nutrition.World Rev Nutr Diet. 2025;128:49-72. doi: 10.1159/000541850. Epub 2025 Feb 19. World Rev Nutr Diet. 2025. PMID: 39970884 Review. No abstract available.
Cited by
-
The Impact of Chronic Alcohol Consumption on Cognitive Function in Older People.J Clin Med. 2025 Jun 28;14(13):4595. doi: 10.3390/jcm14134595. J Clin Med. 2025. PMID: 40648970 Free PMC article.
-
Does low physical activity cause cognitive decline in elderly type 2 diabetes patients: A propensity score matching analysis.World J Diabetes. 2025 Jun 15;16(6):105496. doi: 10.4239/wjd.v16.i6.105496. World J Diabetes. 2025. PMID: 40548265 Free PMC article.
-
The weight-adjusted-waist index and cognitive impairment among U.S. older adults: a population-based study.Front Endocrinol (Lausanne). 2023 Nov 8;14:1276212. doi: 10.3389/fendo.2023.1276212. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027119 Free PMC article.
-
Elevated urine albumin-to-creatinine ratio as a risk factor for cognitive impairment in older adults: A cross-sectional analysis of NHANES data.PLoS One. 2025 May 5;20(5):e0321519. doi: 10.1371/journal.pone.0321519. eCollection 2025. PLoS One. 2025. PMID: 40323962 Free PMC article.
References
-
- El-Tallawy H.N., Saadeldin H.M., Ezzeldin A.M., Tohamy A.M., Eltellawy S., Bathalath A.M., Shehab M.M. Genetic, Clinical, and Biochemical Aspects of Patients with Alzheimer Disease. Egypt. J. Neurol. Psychiatry Neurosurg. 2022;58:24. doi: 10.1186/s41983-022-00455-z. - DOI
-
- Johnson S.C., Koscik R.L., Jonaitis E.M., Clark L.R., Mueller K.D., Berman S.E., Bendlin B.B., Engelman C.D., Okonkwo O.C., Hogan K.J., et al. The Wisconsin Registry for Alzheimer’s Prevention: A Review of Findings and Current Directions. Alzheimers Dement. 2018;10:130–142. doi: 10.1016/j.dadm.2017.11.007. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical